Concentration Ability Impaired clinical trials at UCSF

1 research study open to eligible people

Concentration ability impaired means struggling to focus or think clearly. UCSF is examining how COVID-19 impacts brain health and cognitive abilities. These clinical trials are important for understanding how the virus affects concentration.

Showing trials for

  • Neural and Cognitive Consequences of COVID-19 Survival

    open to eligible people ages 18-70

    The novel coronavirus SARS-CoV-2 infection, COVID, continues to rage throughout the world with 115,000,000 confirmed cases and over 2,500,000 deaths (as of Mar 3, 2021). This translates to millions of people surviving COVID19 infection. While the lungs are ground zero, COVID tears through organ systems from brain to blood vessels. We are now beginning to see people recover but complain of ongoing problems, including lingering cognitive problems, depression, and anxiety. We have brought together 2 laboratories with complementary techniques including psychological testing and neuroimaging methods togethers with markers in the blood that may signal damage in the brain. A close look at these problems is timely and imperative if we are to understand the pathophysiology of 'COVID brain' and prepare for downstream problems.

    San Francisco, California

Our lead scientists for Concentration Ability Impaired research studies include .

Last updated: